Does Nutritional Therapy in Inflammatory Bowel Disease Have a Primary or an Adjunctive Role?

References

• Matuchansky C. Parenteral nutrition in inflammatory bowel disease. Gut 1986; 27: 81–84, suppl 1
   PubMed Web of Science ®Google Scholar
• Dickinson R J, et al. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of bowel colitis. Gastroenterology 1980; 79: 1199–1204
   PubMed Web of Science ®Google Scholar
• O'Morain C, Segal A W, Levi AJ. Elemental diets in the treatment of acute Crohn's disease. Br Med J 1980; 781: 1173–1175
   Google Scholar
• O'Morain C, Segal A W, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease. Br Med J 1984; 288: 1859–1862
   PubMed Web of Science ®Google Scholar
• Sanderson J R, et al. Remission reduced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987; 61: 123–127
   Google Scholar
• Saverymuttu S, Hodgson H J, Chadwick VS. Controlled trial comparing prednisolone with an elemental diet plus nonabsorbable antibiotics in active Crohn's disease. Gut 1985; 25: 994–998
   Google Scholar
• Morin C L, et al. Continuous elemental enteral alimentation in children with Crohn's disease. Gastroenterology 1980; 79: 1205–1210
   PubMed Web of Science ®Google Scholar
• Harries A D, et al. Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet 1983; 1: 887–890
   PubMed Web of Science ®Google Scholar
• Logan R FA, et al. Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut 1981; 22: 381–387
   Web of Science ®Google Scholar
• Kane S P, Neale G. Ileocolitis responding to bowel sterilization. Proc R Soc Med 1976; 69: 266
   PubMedGoogle Scholar
• Wensinck F, et al. Faecal flora of patients with Crohn's disease. J Hyg 1981; 87: 1
   PubMedGoogle Scholar
• Winitz M, et al. Studies in metabolic nutrition employing chemically defined diets. II. Effects on gut microflora populations. Am J Clin Nutr 1970; 23: 546
   PubMed Web of Science ®Google Scholar
• Bounous G, Devroeda GJ. Effects of an elemental diet on human faecal flora. Gastroenterology 1974; 66: 210
   PubMed Web of Science ®Google Scholar
• Attebury H R, Sutter V L, Finegold SM. Effect of a partially chemically defined diet on human faecal flora. Am J Clin Nutr 1972; 23: 546
   Google Scholar
• Hudson M J, Borriello S P, Hill MJ. Elemental diets and the bacterial flora of the gastrointestinal tract, RI Russell. CRC Press, Boca Raton, Fla 1981; 105
   Google Scholar
• Axelsson C K, Justessen T. Studies of the duodenal and faecal flora in gastrointestinal disorders during treatment with an elemental diet. Gastroenterology 1977; 72: 397
   PubMed Web of Science ®Google Scholar
• O'Morain C. Crohn's disease: treatment and pathogenesis. CRC Press, Boca Raton, Fla 1987; 117
   Google Scholar
• Chiodini R J, et al. A possible role of mycobacteria in inflammatory bowel disease. Dig Dis Sci 1984; 29: 1073–1079
   PubMed Web of Science ®Google Scholar
• Wellmann W, Fink P C, Schrindt FW. Whole gut irrigation as anti-endotoxinaemic therapy in inflammatory bowel disease. Hepatogastroenter-ology 1984; 51: 91–93
   Google Scholar
• Wellmann W, Fink P C, Benner F, Schmidt F W, et al. Endotoxinaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-amino-salicylic acid. Gut 1986; 27: 814–820
   PubMed Web of Science ®Google Scholar
• Suzuki I, et al. Abrogation of oral tolerance by contrasuppressor T cells suggests the presence of regulator T cell networks in the mucosal immune system. Nature 1986; 320: 451–454
   PubMed Web of Science ®Google Scholar
• Alun Jones V, et al. Crohn's disease: Maintenance of remission by diet. Lancet 1985; 2: 177–180
   PubMed Web of Science ®Google Scholar
• Bohen T, et al. Decreased lysophospholipase and increased phospholipase A2, activity in ileal mucosa from patients with Crohn's disease. Br Med J 1984; 288: 1859
   PubMed Web of Science ®Google Scholar
• O'Morain C, et al. Chromium 51-ethylenediamine-tetraacetate test. A useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986; 108: 430
   PubMed Web of Science ®Google Scholar
• Howells B, et al. Agglutinins to anaerobic bacteria in Crohn's disease and in Indian patients with diarrhea. J Med Microbiol 1984; 17: 207
   PubMed Web of Science ®Google Scholar
• Blaser M J, et al. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984; 87: 888
   PubMed Web of Science ®Google Scholar
• Wandall J H, Binder V. Leucocyte function in ulcerative colitis, quantitative leucocyte mobilisation into skin window and in vitro function of blood leucocytes. Gut 1982; 23: 958
   Google Scholar
• O'Morain C A, et al. Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut 1981; 22: 817–822
   PubMed Web of Science ®Google Scholar
• Verspaget H W, et al. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 1988; 29: 223–228
   PubMed Web of Science ®Google Scholar
• Millers B, et al. Zuckerkonsum bie patienten mit morbus Crohn. Verh Dtsch Ges Inn Med 1976; 82: 922–924
   PubMedGoogle Scholar
• Martini G A, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 1976; 54: 367–371
   PubMedGoogle Scholar
• Kasper H, Sommer H. Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr 1979; 32: 1898–1901
   PubMed Web of Science ®Google Scholar
• Thornton J R, Emmett P M, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. BMJ 1979; 2: 762–764
   PubMed Web of Science ®Google Scholar
• Mayberry J F, Rhodes J, Newcombe RG. Increased sugar consumption in Crohn's disease. Digestion 1980; 20: 323–326
   PubMed Web of Science ®Google Scholar
• Silkoff K, et al. Consumption of refined carbohydrate by patients with Crohn's disease in Tel-Aviv-Yafo. Postgrad Med J 1980; 56: 842–846
   PubMed Web of Science ®Google Scholar
• Mayberry J F, et al. Diet in Crohn's disease. Two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981; 26: 444–448
   PubMed Web of Science ®Google Scholar
• Jarnerot G, Jarnmark I, Nilsson K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis or irritable bowel syndrome. Scand J Gastroenterol 1983; 18: 999–1002
   PubMed Web of Science ®Google Scholar
• Heaton K W, Thornton J R, Emmett PM. Treatment of Crohn's disease with an unrefined-carbohydrate, fibre rich diet. Br Med J 1979; 2: 764–766
   PubMed Web of Science ®Google Scholar
• Ritchie J K, et al. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. Br Med J 1987; 295: 517–520
   PubMed Web of Science ®Google Scholar
• Levenstein S, et al. Low residue or normal diet in Crohn's disease. Gut 1985; 26: 989–993
   PubMed Web of Science ®Google Scholar
• Jacobs L R, Luptor JR. Effect of dietary fiber on rat large bowel mucosal growth and cell proliferation. Am J Physiol 1984; 246: 378–385
   PubMedGoogle Scholar
• O'Morain C A, et al. Organelle pathology in ulcerative colitis with specific reference to lysosomes. Gut 1984; 25: 455–459
   PubMed Web of Science ®Google Scholar
• Reddy B S, Sharma S C, Matthews L. Faecal mitogens from subjects consuming a mixed western diet. MutatRes 1985; 135: 11–19
   Google Scholar
• Hill M J, et al. Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet 1987; 2: 185–6
   PubMed Web of Science ®Google Scholar